James Engelhart, Chief Financial Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), bought 2,500 shares at $43.05 ($108K) on 2019-06-27, disclosed to the SEC on 2019-06-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| BHVN | SELL | 2018-05-30 | $175K | — | Filing → |
| BHVN | SELL | 2018-05-09 | $69K | — | Filing → |
| BHVN | SELL | 2018-02-23 | $16K | — | Filing → |